Genetic testing firm Ambry Genetics and Pacific Biosciences of California Inc. are working together to find the genetic cause of rare diseases in pediatric patients.PacBio (Nasdaq: PACB), a biotechnology company in Menlo Park valued at $524 million, manufactures gene sequencing technology for scientists and clinical researchers.
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) gapped down prior to trading on Thursday . The stock had previously closed at $1.82, but opened at $1.78. Pacific Biosciences of California shares last traded at $1.84, with a volume of 2,907,306 shares changing hands. Wall Street Analysts Forecast Growth Several research analysts have […]
Decheng Capital LLC Invests $28.85 Million in Pacific Biosciences of California, Inc. (NASDAQ:PACB) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced by some of its major holdings.